BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4248512)

  • 41. [Use of different drug forms of novobiocin in dermatological practice].
    Panichkina GS
    Vestn Dermatol Venerol; 1981 Jan; (1):43-7. PubMed ID: 7210869
    [No Abstract]   [Full Text] [Related]  

  • 42. Neutropenia associated with vancomycin therapy.
    Kauffman CA; Severance PJ; Silva J; Huard TK
    South Med J; 1982 Sep; 75(9):1131-3. PubMed ID: 7123341
    [No Abstract]   [Full Text] [Related]  

  • 43. Introduction to vancomycin.
    Griffith RS
    Rev Infect Dis; 1981; 3 suppl():S200-4. PubMed ID: 7043707
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Infections in heroin addicts.
    Darrell JH
    Lancet; 1967 Dec; 2(7530):1363. PubMed ID: 4170050
    [No Abstract]   [Full Text] [Related]  

  • 45. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
    Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment of mitral MRSA endocarditis using daptomycin].
    Senneville E; Beltrand E; Legout L; Leroy O; Fayad G
    Med Mal Infect; 2008 Dec; 38 Spec No 2():13-5. PubMed ID: 19185204
    [No Abstract]   [Full Text] [Related]  

  • 47. Comparative efficacy of novobiocin and amoxicillin in experimental sepsis caused by beta-lactam-susceptible and highly resistant pneumococci.
    Rodríguez-Cerrato V; Del Prado G; Huelves L; Naves P; Ruiz V; García E; Ponte C; Soriano F
    Int J Antimicrob Agents; 2010 Jun; 35(6):544-9. PubMed ID: 20303716
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diarrhea associated with parenteral vancomycin therapy.
    Schenfeld LA; Pote HH
    Clin Infect Dis; 1995 Jun; 20(6):1578-9. PubMed ID: 7548526
    [No Abstract]   [Full Text] [Related]  

  • 49. [Infectious endocarditis 100 years after Osler].
    Fernández-Guerrero ML
    Enferm Infecc Microbiol Clin; 1996; 14(6):377-83. PubMed ID: 8756217
    [No Abstract]   [Full Text] [Related]  

  • 50. Vancomycin.
    Kucers A
    J Antimicrob Chemother; 1984 Dec; 14(6):564-7. PubMed ID: 6394568
    [No Abstract]   [Full Text] [Related]  

  • 51. Vancomycin-streptomycin synergism in enterococcal endocarditis.
    Westenfelder GO; Paterson PY; Reisberg BE; Carlson GM
    JAMA; 1973 Jan; 223(1):37-40. PubMed ID: 4739084
    [No Abstract]   [Full Text] [Related]  

  • 52. Increased dose requirements of vancomycin in a pregnant patient with endocarditis.
    Salzman C; Weingold AB; Simon GL
    J Infect Dis; 1987 Aug; 156(2):409. PubMed ID: 3598241
    [No Abstract]   [Full Text] [Related]  

  • 53. Vancomycin.
    Geraci JE
    Mayo Clin Proc; 1977 Oct; 52(10):631-4. PubMed ID: 909314
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative efficacy of amoxycillin + clavulanic acid (augmentin), flucloxacillin and vancomycin against S. aureus endocarditis in the rat.
    Catherall EJ; Irwin R; Mizen L
    J Chemother; 1989 Jul; 1(4 Suppl):69-70. PubMed ID: 16312308
    [No Abstract]   [Full Text] [Related]  

  • 55. Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.
    Chambers HF
    Antimicrob Agents Chemother; 2005 Mar; 49(3):884-8. PubMed ID: 15728879
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Severe staphylococcal infections treated with vancomycin.
    Cafferkey MT; Hone R; Keane CT
    J Antimicrob Chemother; 1982 Jan; 9(1):69-74. PubMed ID: 7061356
    [No Abstract]   [Full Text] [Related]  

  • 57. Desensitization in the management of vancomycin hypersensitivity.
    Lin RY
    Arch Intern Med; 1990 Oct; 150(10):2197-8. PubMed ID: 2222107
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of in vitro susceptibility phenotype against thrombin-induced platelet microbicidal protein on treatment and prophylaxis outcomes of experimental Staphylococcus aureus endocarditis.
    Dhawan VK; Yeaman MR; Bayer AS
    J Infect Dis; 1999 Nov; 180(5):1561-8. PubMed ID: 10515816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibiotic-associated pseudomembranous colitis: 1980.
    Tedesco FJ
    Compr Ther; 1980 Jan; 6(1):15-7. PubMed ID: 7053191
    [No Abstract]   [Full Text] [Related]  

  • 60. Vancomycin-induced linear IgA bullous dermatosis demonstrating the isomorphic phenomenon.
    Choudhry SZ; Kashat M; Lim HW
    Int J Dermatol; 2015 Nov; 54(11):1211-3. PubMed ID: 26227580
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.